Analyst Price Targets — INSP
Latest News for INSP
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Inspire Medical Systems, Inc. (NYSE: INSP). In August of 2025, contrary to the Company's repeated assurances that it had met all regulatory, technical, and commercial prerequisites for the launch…
Inspire Medical Systems, Inc. (NYSE: INSP - Get Free Report) gapped down before the market opened on Friday. The stock had previously closed at $68.05, but opened at $63.02. Inspire Medical Systems shares last traded at $62.9650, with a volume of 315,166 shares. Analysts Set New Price Targets A number of brokerages have recently commented
NEW YORK and NEW ORLEANS, Feb. 13, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
Inspire Medical Systems faces intensifying competition, reimbursement headwinds, and decelerating growth in the obstructive sleep apnea device market. Despite Q4 revenue and EPS beats, FY26 guidance implies just 4–10% revenue growth, higher capex, and a projected net loss amid operational challenges. Valuation remains stretched even after a 66% stock decline; DCF analysis suggests current pricing bakes in optimistic…
INSP beats Q4 estimates with EPS up 43% and wider margins, but shares tumble 8.7% after a lower 2026 revenue outlook.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for INSP.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.